Features
Current Status and Needs in Teleglaucoma
Technology has great potential for the future of glaucoma care.
By Anna Do, MD, Lama A. Al-Aswad, MD, MPH
Ergonomics for the Glaucoma Physician
Prevent musculoskeletal disorders in day-to-day practice.
By Amer Alwreikat, MD, Shiyoung Roh, MD, Jeffrey L. Marx, MD
Glaucoma in Eyes With Intraocular Tumors
Complex glaucomas can be controlled without jeopardizing patient health.
By Nicholas Tan, BA, Nathan M. Radcliffe, MD, Paul T. Finger, MD
Strategies for Optic Nerve Regeneration
Where are we now?
By Micalla Peng, MS, Heidi Ansorge, Basheer Alas, BS, et al.
KDB Goniotomy Combines Quality Care With an Established CPT Code
As a stand-alone procedure or combined with cataract surgery, KDB goniotomy provides excellent clinical results and exceeds margins for MIGS.
By Andrew G. Iwach, MD
Web Exclusives
Improving Patient Compliance With Compounded Glaucoma Medications
Reduce the number of drops by combining medications into one bottle.
By Steven R. Sarkisian, Jr., MD
Tonometry and Tonometer Disinfection in the COVID-19 Era
Consider the data and put safety first.
By Nicholas Tan, BA, Nathan M. Radcliffe, MD
Departments
From the Editor: Finding a New Normal in Glaucoma
By Nathan M. Radcliffe, MD
Coding: Changes to Extended Ophthalmoscopy Coding for Glaucoma Patients
2020 brings a major update to coding.
By RIVA LEE ASBELL
Case Files: A Case of Acute Iris Depigmentation
Gonioscopy-assisted transluminal trabeculotomy restored outflow.
By Daniel Lee, MD
News
Glaucoma Survey Assesses Disruption From Coronavirus
Patients report little interest in telehealth.
By Jerry Helzner, contributing editor
Haag-Streit Introduces New Surgical Chair Design
By Jerry Helzner, contributing editor
Glaucoma Practice in the COVID-19 Era
By Jerry Helzner, contributing editor
Guidelines for Reopening Ambulatory Surgery Centers
By Jerry Helzner, contributing editor
iSTAR MIGS Implant Effective in Two Trials
By Jerry Helzner, contributing editor
AI-Supported Test Gives Early Warning on Glaucoma Progression
By Jerry Helzner, contributing editor
Graybug Studying Sustained-Release Glaucoma Drug
By Jerry Helzner, contributing editor
Iridex Introduces New MicroPulse Device
By Jerry Helzner, contributing editor
Ocular Therapeutix: Positive Data on Long-Term Implant
By Jerry Helzner, contributing editor
New Type of Perimetry Found Highly Accurate
By Jerry Helzner, contributing editor
China Uses Real-World Data to Approve Xen Stent
By Jerry Helzner, contributing editor
Incarcerated Glaucoma Patients Struggle With Adherence
By Jerry Helzner, contributing editor
Nicox Clinical Trial Update
By Jerry Helzner, contributing editor
Understanding the Causes of Pseudoexfoliation Glaucoma
By Jerry Helzner, contributing editor
Xen-Augmented Baerveldt vs Ahmed Glaucoma Valve
By Jerry Helzner, contributing editor
Glaucoma May Be Treatable by Gene Therapy
By Jerry Helzner, contributing editor
Study: Raising Eye Pressure Causes Glaucoma
By Jerry Helzner, contributing editor
Verana Health Will Handle End-to-End IRIS Registry Administration
By Jerry Helzner, contributing editor
Trabeculotomy Combination Procedure Effective in Cataract-Glaucoma Surgery
By Jerry Helzner, contributing editor
New, Detailed Phase 3 Data on Durysta Implant Presented at ASCRS
By Jerry Helzner, contributing editor
Goniotomy With Kahook Blade in Cataract Surgery Effective
By Jerry Helzner, contributing editor
Patient Satisfaction With Glaucoma Eye Drops
By Jerry Helzner, contributing editor
MIGS Decision-Making Discussed at ASCRS
By Jennifer Ford, content director